Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Gross Sales	$ 8,868,093	$ 11,352,585	$ 28,673,718	$ 36,941,917
Allowances	(275,200)	(792,062)	(1,130,117)	(2,254,481)
Total Net Sales	8,592,893	10,560,523	27,543,601	34,687,436
Cost of sales	2,660,185	3,370,952	10,176,085	10,444,353
Gross Profit	5,932,708	7,189,571	17,367,516	24,243,083
Operating expenses	8,282,931	13,865,191	31,690,915	36,846,371
Impairment of goodwill and other intangible assets	30,776,436	0	48,959,721	0
Loss from operations	(33,126,659)	(6,675,620)	(63,283,120)	(12,603,288)
Realized and Unrealized (loss) gain on marketable and other securities, including impairments		(18,623)	(33,352)	526,940
Gain (loss) on extinguishment of debt	0	1,466,113		1,466,113
Decrease (increase) of contingent liability	1,943,000	6,871,000	8,246,000	(10,500,000)
Gain (loss) on sale of assets	88,769		88,769
Restructuring expense	(602,092)	0	(602,092)	0
Other income	64,390	0	137,377	0
Interest expense	(1,551)	(2,582)	(6,871)	(23,573)
Loss before provision for income taxes	(31,634,143)	1,640,288	(55,453,289)	(21,133,808)
Benefit for income taxes	0	(103,000)	0	765,000
Net (Loss) Income	(31,634,143)	1,537,288	(55,453,289)	(20,368,808)
Preferred dividends	1,000,501	560,281	3,001,503	1,220,610
Net (Loss) Income attributable to cbdMD, Inc. common shareholders	$ (32,634,644)	$ 977,007	$ (58,454,792)	$ (21,589,418)
Net (Loss) Income per share:
Basic earnings per share (in dollars per share)	$ (0.55)	$ 0.02	$ (0.99)	$ (0.40)
Diluted earnings per share (in dollars per share)	$ (0.55)	$ 0.02	$ (0.99)	$ (0.40)
Weighted average number of shares Basic: (in shares)	59,316,762	56,676,326	59,229,208	54,089,263
Shares used in computing diluted earnings per share (in shares)	59,316,762	61,431,643	59,229,208	54,089,263